|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Total Current Assets | |||||||||
| Cash held in Trust Account | |||||||||
| Cash and marketable securities held in Trust Account | |||||||||
| TOTAL ASSETS | |||||||||
| Current liabilities | |||||||||
| Accrued offering costs | |||||||||
| Accrued expenses | |||||||||
| Excise tax payable | |||||||||
| Income taxes payable | |||||||||
| Loans outstanding | |||||||||
| Total Current Liabilities | |||||||||
| Warrant liabilities | |||||||||
| Deferred tax liability | |||||||||
| Deferred underwriting fee payable | |||||||||
| Total Liabilities | |||||||||
| Class A common stock subject to possible redemption 25,000,000 and no shares at redemption value of $10.00 and $0.00 at December 31, 2021 and 2020, respectively | |||||||||
| Class A common stock subject to possible redemption 6,255,019 and 25,000,000 shares at redemption value of approximately $10.15 and $10.09 at March 31, 2023 and December 31, 2022, respectively | |||||||||
| Stockholders’ Deficit | |||||||||
| Class A common stock, $0.0001 par value; 75,000,000 shares authorized; no shares issued and outstanding (excluding 6,255,019 and 25,000,000 shares subject to possible redemption) at March 31, 2023 and December 31, 2022, respectively | |||||||||
| Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 6,250,000 shares issued and outstanding at March 31, 2023 and December 31, 2022 | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total Stockholders’ Deficit | |||||||||
| TOTAL LIABILITIES, COMMITMENTS AND CONTINGENCIES, REDEEMABLE CLASS A COMMON STOCK AND STOCKHOLDERS’ DEFICIT |
Loading...
